82 Despite knowledge of the importance of the avoidance of weight gain in people with SMI, there is a paucity of evidence for the acceptability of metformin among people with SMI and, in particular, among younger people for whom factors such as pill burden may be significant.
← all excerpts
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation.
1
—
—